» Journals » Neuropsychopharmacol Hung

Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakológiai Egyesület Lapja

Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakológiai Egyesület Lapja is a scientific journal, published since 1999 in Hungarian. The journal's country of origin is Hungary and its primary focus areas are neurology, pharmacology and psychiatry.

Details
Abbr. Neuropsychopharmacol Hung
Start 1999
End Continuing
Frequency Quarterly
p-ISSN 1419-8711
e-ISSN 2064-2512
Country Hungary
Language Hungarian
Metrics
h-index / Ranks: 12784 18
SJR / Ranks: 12818 242
CiteScore / Ranks: 11984 1.40
Recent Articles
1.
Zwiebel S, De Leon J
Neuropsychopharmacol Hung . 2025 Jan; 26(4):243-260. PMID: 39760677
Objective: Benzodiazepines, particularly lorazepam, are good options for acute catatonia treatment. Published catatonia literature on benzodiazepine maintenance treatment and benzodiazepine tolerance is limited. Methods: This is a chart review covering...
2.
Sikter A
Neuropsychopharmacol Hung . 2025 Jan; 26(4):227-242. PMID: 39760676
The discovery of the functioning of intra- and extracellular ion compartments and cell membranes' operation opened the possibility of extending Claude Bernard's theory to intracellular ions. In contrast, by underestimating...
3.
Vass A, Csukly G, Farkas K
Neuropsychopharmacol Hung . 2025 Jan; 26(4):218-226. PMID: 39760675
Aims: Autism spectrum disorder and schizophrenia are traditionally viewed as distinct diagnostic categories. However, evidence increasingly suggests overlapping pathological functioning at various levels, starting from brain circuitry to behaviour. Notably,...
4.
Miklosi M, Hayes H, Gallai M
Neuropsychopharmacol Hung . 2025 Jan; 26(4):204-217. PMID: 39760674
Background/objective: Behavioural Parent Training (BPT) is an evidence-based psychosocial intervention for attention-deficit/hyperactivity disorder (ADHD) in children. The use of online technologies significantly increases the accessibility of these interventions. This study...
5.
Nagy T, Baksa D, Petschner P, Gonda X, Gal Z, Juhasz G, et al.
Neuropsychopharmacol Hung . 2025 Jan; 26(4):197-203. PMID: 39760673
Background: Major depressive disorder (MDD) is a complex psychiatric condition significantly impacted by environmental stress and inflammation. Previous research suggests that stress-induced alterations in the blood-brain barrier (BBB) may allow...
6.
Kornyei-Horvath P, Illes S, Csenki-Knyihar A
Neuropsychopharmacol Hung . 2024 Oct; 26(3):182-188. PMID: 39360492
Endometriosis is a common gynecological disease affecting 5-10% of women resulting in several psychological impacts. Regarding the high prevalence as well as extensive somatic symptoms, this has become a growing...
7.
Tahan M, Azari F, Saleem T
Neuropsychopharmacol Hung . 2024 Oct; 26(3):170-181. PMID: 39360491
Background: The Islamic Republic of Iran has been under sanctions since 1979. These sanctions were further reinforced between the years 2005 and 2012. This study utilizes available data from Iran...
8.
Ayer L, Horowitz L, Colpe L, Lowry N, Ryan P, Boudreux E, et al.
Neuropsychopharmacol Hung . 2024 Oct; 26(3):153-169. PMID: 39360490
Suicide is a serious public health concern. On average, 80% of suicide decedents had contact with primary care within one year of their suicide. This and other research underscore the...
9.
Fulop F, Demeter G, Honbolygo F, Csigo K
Neuropsychopharmacol Hung . 2024 Oct; 26(3):144-152. PMID: 39360489
Objectives: The prevalence of clinical obsessive-compulsive disorder (OCD) is around 1-2% in the population. Questionnaires, such as the OCI-R, are a useful tool in the diagnositc process. The purpose of...
10.
Mohandoss A, Thavarajah R
Neuropsychopharmacol Hung . 2024 Oct; 26(3):133-143. PMID: 39360488
Background: The addictive potential of areca nut (AN) and tobacco is well-documented, but their combined neurobiological effects in AN-containing tobacco products (ANTP) remain obscure. This study employed a three-stage in...